|
⚲
|
| Thoma Bravo Special Opportunities Fund II-A Global LP | |
|---|---|
| Firm |
Thoma Bravo LP
✚
|
| Fund # | 805-8141038730 |
| CIK # | |
| Sale | |
| Fund | Private Equity Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | Thoma Bravo Partners Xi Global LP |
| Custodian | JP Morgan Chase Bank NA, Merrill Lynch Pierce Fenner & Smith Incorporated |
| Auditor | Ernst & Young LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Medica John K
✚
|
0.0 | |
|
Medical Innovation Centers of America, Inc.
✚
|
0.0 | |
|
MediCall Inc.
✚
|
0.0 | |
|
MedicalMatch Corp
✚
|
0.0 | |
|
Medicenna Therapeutics Corp.
✚
|
0.0 | |
|
Atlas Portable Alpha, L.P.
✚
|
0.0 | |
|
Atlas Private Markets Fund I, L.P.
✚
|
0.0 | |
|
Atlas Sciences, LLc
✚
|
0.0 | |
|
Atlas Technical Consultants Holdings GP LLC
✚
|
0.0 | |
|
Elyseum Suisse Sa
✚
|
0.0 |